Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
WLK Stock Summary
Top 10 Correlated ETFs
WLK
In the News
Westlake (WLK) Up 11% Since Last Earnings Report: Can It Continue?
Westlake (WLK) reported earnings 30 days ago. What's next for the stock?
Westlake (WLK) Unveils Cellular PVC-Made Royal WoodTone Styles
The Royal WoodTone Styles by Westlake (WLK) add both sophistication and functionality to porch ceilings and soffit applications.
Westlake (WLK) Gets ISCC PLUS Certification at its Germany Site
This recent certification illustrates Westlake's (WLK) continued commitment to being more ecologically friendly.
Westlake (WLK) Arm to Unveil New Roofing Products at the IBS
The Unified Steel Material List Generator is the first of four new products Westlake (WLK) Royal will introduce at this year's IBS.
Westlake's (WLK) Earnings and Sales Miss Estimates in Q4
Westlake's (WLK) fourth-quarter earnings and revenues miss the respective estimates amid reduced selling prices in PEM.
Westlake Corporation (WLK) Q4 2023 Earnings Call Transcript
Westlake Corporation (WLK) Q4 2023 Earnings Call Transcript
Westlake (WLK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Westlake (WLK) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Westlake Chemical (WLK) Lags Q4 Earnings and Revenue Estimates
Westlake Chemical (WLK) came out with quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $1.79 per share a year ago.
Seeking Clues to Westlake (WLK) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Westlake (WLK) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Earnings Preview: Westlake Chemical (WLK) Q4 Earnings Expected to Decline
Westlake (WLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WLK Financial details
WLK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 63.23 | 58.69 | 92.01 | 123.42 | 98.18 | |
Net income per share | 3.28 | 2.58 | 15.74 | 17.56 | 3.75 | |
Operating cash flow per share | 10.13 | 10.14 | 18.7 | 26.53 | 18.28 | |
Free cash flow per share | 4 | 6.04 | 13.56 | 17.87 | 10.19 | |
Cash per share | 5.67 | 10.27 | 14.91 | 17.41 | 25.85 | |
Book value per share | 45.64 | 47.27 | 62.15 | 77.6 | 80.13 | |
Tangible book value per share | 35.97 | 38.19 | 38.47 | 52.66 | 57.27 | |
Share holders equity per share | 45.64 | 47.27 | 62.15 | 77.6 | 80.13 | |
Interest debt per share | 28.72 | 29.06 | 41.84 | 40.44 | 39.68 | |
Market cap | 9.01B | 10.43B | 12.43B | 13.12B | 17.89B | |
Enterprise value | 11.72B | 12.69B | 15.7B | 15.77B | 19.49B | |
P/E ratio | 21.39 | 31.61 | 6.17 | 5.84 | 37.34 | |
Price to sales ratio | 1.11 | 1.39 | 1.06 | 0.83 | 1.43 | |
POCF ratio | 6.92 | 8.04 | 5.19 | 3.87 | 7.66 | |
PFCF ratio | 17.52 | 13.51 | 7.16 | 5.74 | 13.74 | |
P/B Ratio | 1.54 | 1.73 | 1.56 | 1.32 | 1.75 | |
PTB ratio | 1.54 | 1.73 | 1.56 | 1.32 | 1.75 | |
EV to sales | 1.44 | 1.69 | 1.33 | 1 | 1.55 | |
Enterprise value over EBITDA | 8.12 | 9.9 | 4.23 | 3.74 | 8.37 | |
EV to operating cash flow | 9.01 | 9.78 | 6.56 | 4.65 | 8.34 | |
EV to free cash flow | 22.81 | 16.43 | 9.05 | 6.9 | 14.97 | |
Earnings yield | 0.05 | 0.03 | 0.16 | 0.17 | 0.03 | |
Free cash flow yield | 0.06 | 0.07 | 0.14 | 0.17 | 0.07 | |
Debt to equity | 0.61 | 0.59 | 0.65 | 0.5 | 0.48 | |
Debt to assets | 0.27 | 0.26 | 0.28 | 0.24 | 0.23 | |
Net debt to EBITDA | 1.88 | 1.76 | 0.88 | 0.63 | 0.69 | |
Current ratio | 2.21 | 2.56 | 2.25 | 2.6 | 2.37 | |
Interest coverage | 5.29 | 3.02 | 15.91 | 17.23 | 7.47 | |
Income quality | 2.82 | 3.48 | 1.16 | 1.48 | 4.88 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.31 | 0.42 | 0.07 | 0.08 | 0.46 | |
Sales general and administrative to revenue | 0 | 0.06 | 0.04 | 0.05 | 0.07 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.13 | 0.12 | 0.2 | 0.18 | 0.16 | |
Capex to operating cash flow | -0.6 | -0.4 | -0.27 | -0.33 | -0.44 | |
Capex to revenue | -0.1 | -0.07 | -0.06 | -0.07 | -0.08 | |
Capex to depreciation | -1.1 | -0.68 | -0.78 | -1.05 | -0.94 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 58.03 | 52.39 | 148.36 | 175.1 | 82.2 | |
ROIC | 0.05 | 0.05 | 0.16 | 0.15 | 0.06 | |
Return on tangible assets | 0.04 | 0.03 | 0.14 | 0.13 | 0.03 | |
Graham Net | -38.05 | -35.78 | -46.24 | -43.55 | -38.77 | |
Working capital | 1.5B | 2.12B | 2.92B | 3.68B | 3.82B | |
Tangible asset value | 4.62B | 4.88B | 4.92B | 6.74B | 7.32B | |
Net current asset value | -4.12B | -3.78B | -4.67B | -4.11B | -3.66B | |
Invested capital | 0.61 | 0.59 | 0.65 | 0.5 | 0.48 | |
Average receivables | 1.04B | 1.13B | 1.54B | 1.83B | 1.7B | |
Average payables | 490M | 501M | 696.5M | 867M | 1.68B | |
Average inventory | 975M | 927M | 1.16B | 1.64B | 1.74B | |
Days sales outstanding | 46.58 | 59.05 | 57.89 | 41.62 | 46.57 | |
Days payables outstanding | 25.17 | 29.79 | 38.07 | 27.09 | 87 | |
Days of inventory on hand | 49.82 | 51.7 | 62 | 58.11 | 56.65 | |
Receivables turnover | 7.84 | 6.18 | 6.31 | 8.77 | 7.84 | |
Payables turnover | 14.5 | 12.25 | 9.59 | 13.47 | 4.2 | |
Inventory turnover | 7.33 | 7.06 | 5.89 | 6.28 | 6.44 | |
ROE | 0.07 | 0.05 | 0.25 | 0.23 | 0.05 | |
Capex per share | -6.13 | -4.11 | -5.14 | -8.66 | -8.09 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 25.87 | 26.31 | 25.47 | 24.36 | 22.05 | |
Net income per share | 1.82 | 3.09 | 2.33 | 2.23 | -3.88 | |
Operating cash flow per share | 6.55 | 4.01 | 4.35 | 5.44 | 4.47 | |
Free cash flow per share | 4.22 | 1.92 | 2.47 | 3.53 | 2.27 | |
Cash per share | 17.47 | 18.93 | 20.97 | 23.91 | 25.78 | |
Book value per share | 77.87 | 80.68 | 82.6 | 84.11 | 79.9 | |
Tangible book value per share | 52.84 | 63.47 | 57.99 | 67.15 | 57.11 | |
Share holders equity per share | 77.87 | 80.68 | 82.6 | 84.11 | 79.9 | |
Interest debt per share | 39.53 | 38.7 | 38.69 | 38.43 | 38.6 | |
Market cap | 13.08B | 14.79B | 15.25B | 15.94B | 17.94B | |
Enterprise value | 15.73B | 17.27B | 17.47B | 17.76B | 19.54B | |
P/E ratio | 14.09 | 9.39 | 12.84 | 13.98 | -9.02 | |
Price to sales ratio | 3.96 | 4.41 | 4.69 | 5.12 | 6.35 | |
POCF ratio | 15.66 | 28.89 | 27.48 | 22.9 | 31.31 | |
PFCF ratio | 24.31 | 60.38 | 48.41 | 35.34 | 61.64 | |
P/B Ratio | 1.32 | 1.44 | 1.45 | 1.48 | 1.75 | |
PTB ratio | 1.32 | 1.44 | 1.45 | 1.48 | 1.75 | |
EV to sales | 4.77 | 5.15 | 5.37 | 5.7 | 6.91 | |
Enterprise value over EBITDA | 40.54 | 20.86 | 25.21 | 26.03 | 86.08 | |
EV to operating cash flow | 18.84 | 33.73 | 31.47 | 25.51 | 34.1 | |
EV to free cash flow | 29.23 | 70.49 | 55.45 | 39.37 | 67.15 | |
Earnings yield | 0.02 | 0.03 | 0.02 | 0.02 | -0.03 | |
Free cash flow yield | 0.04 | 0.02 | 0.02 | 0.03 | 0.02 | |
Debt to equity | 0.5 | 0.48 | 0.46 | 0.45 | 0.48 | |
Debt to assets | 0.24 | 0.24 | 0.23 | 0.23 | 0.23 | |
Net debt to EBITDA | 6.83 | 2.99 | 3.2 | 2.66 | 7.06 | |
Current ratio | 2.6 | 2.85 | 2.95 | 2.54 | 2.37 | |
Interest coverage | 7.6 | 12.76 | 9.43 | 8.73 | -1.34 | |
Income quality | 3.37 | 1.26 | 1.81 | 2.36 | -1.15 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.2 | 0.12 | 0.15 | 0.22 | -0.13 | |
Sales general and administrative to revenue | 0.05 | 0.07 | 0.07 | 0.07 | 0.08 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.18 | 0.13 | 0.18 | 0.13 | 0.16 | |
Capex to operating cash flow | -0.36 | -0.52 | -0.43 | -0.35 | -0.49 | |
Capex to revenue | -0.09 | -0.08 | -0.07 | -0.08 | -0.1 | |
Capex to depreciation | -1.1 | -1 | -0.89 | -0.88 | -1 | |
Stock based compensation to revenue | 0 | 0 | 0 | -0.03 | 0 | |
Graham number | 56.46 | 74.88 | 65.76 | 64.95 | 83.5 | |
ROIC | 0.02 | 0.03 | 0.02 | 0.02 | 0 | |
Return on tangible assets | 0.01 | 0.02 | 0.02 | 0.02 | -0.03 | |
Graham Net | -43.7 | -41.29 | -39.17 | -37.26 | -38.66 | |
Working capital | 3.68B | 3.99B | 4.17B | 4.1B | 3.82B | |
Tangible asset value | 6.74B | 8.1B | 7.4B | 8.59B | 7.32B | |
Net current asset value | -4.11B | -3.83B | -3.61B | -3.35B | -3.66B | |
Invested capital | 0.5 | 0.48 | 0.46 | 0.45 | 0.48 | |
Average receivables | 1.99B | 1.82B | 1.85B | 1.9B | 1.77B | |
Average payables | 931M | 849M | 806.5M | 798M | 1.65B | |
Average inventory | 1.95B | 1.85B | 1.76B | 1.67B | 1.65B | |
Days sales outstanding | 49.13 | 49.21 | 51.35 | 56.02 | 50.99 | |
Days payables outstanding | 28.66 | 29.06 | 27.08 | 28.86 | 84.38 | |
Days of inventory on hand | 61.47 | 64.66 | 57.64 | 59.5 | 54.94 | |
Receivables turnover | 1.83 | 1.83 | 1.75 | 1.61 | 1.77 | |
Payables turnover | 3.14 | 3.1 | 3.32 | 3.12 | 1.07 | |
Inventory turnover | 1.46 | 1.39 | 1.56 | 1.51 | 1.64 | |
ROE | 0.02 | 0.04 | 0.03 | 0.03 | -0.05 | |
Capex per share | -2.33 | -2.09 | -1.88 | -1.92 | -2.2 |
WLK Frequently Asked Questions
What is Westlake Chemical Corporation stock symbol ?
Westlake Chemical Corporation is a US stock , located in Houston of Tx and trading under the symbol WLK
Is Westlake Chemical Corporation buy or a sell ?
6 stock analysts have 6 predictions with a medium analyst target price of $124.5. The lowest prediction is $104 and the highest is $150
What is WLK stock prediction ?
What is Westlake Chemical Corporation stock quote today ?
Westlake Chemical Corporation stock price is $152.505 today.
Is Westlake Chemical Corporation stock public?
Yes, Westlake Chemical Corporation is a publicly traded company.